Published in Behav Pharmacol on September 01, 2011
The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest (2006) 8.43
beta-adrenergic receptor blockade in chronic heart failure. Circulation (2000) 3.43
Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation (1998) 2.35
Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model. Am J Respir Cell Mol Biol (2007) 2.24
Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma. Proc Natl Acad Sci U S A (2004) 1.85
The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study. Pulm Pharmacol Ther (2007) 1.61
Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol (1995) 1.55
Beta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine model. Proc Natl Acad Sci U S A (2009) 1.53
New perspectives regarding β(2) -adrenoceptor ligands in the treatment of asthma. Br J Pharmacol (2011) 1.46
Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation (1995) 1.40
Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma model. Pulm Pharmacol Ther (2007) 1.30
Is paradoxical pharmacology a strategy worth pursuing? Trends Pharmacol Sci (2001) 1.21
Response to salbutamol in patients with mild asthma treated with nadolol. Eur Respir J (2010) 1.07
Inverse agonism: from curiosity to accepted dogma, but is it clinically relevant? Curr Opin Pharmacol (2007) 1.01
5-HT(1A) receptor activation: new molecular and neuroadaptive mechanisms of pain relief. Curr Opin Investig Drugs (2006) 0.99
Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis. Reprod Biol Endocrinol (2010) 0.96
Getting to the heart of asthma: can "beta blockers" be useful to treat asthma? Pharmacol Ther (2007) 0.94
Can intellectualism stifle scientific discovery? Nat Rev Drug Discov (2002) 0.94
Curative-like analgesia in a neuropathic pain model: parametric analysis of the dose and the duration of treatment with a high-efficacy 5-HT(1A) receptor agonist. Eur J Pharmacol (2007) 0.89
Clinical implications of the intrinsic efficacy of beta-adrenoceptor drugs in asthma: full, partial and inverse agonism. Curr Opin Pulm Med (2010) 0.87
Role of spinal 5-HT(1A) receptors in morphine analgesia and tolerance in rats. Eur J Pain (2004) 0.87
Cardiotonic agents in the management of chronic cardiac failure. Am Heart J (1982) 0.86
beta-Adrenoceptor inverse agonists in asthma. Curr Opin Pharmacol (2010) 0.86
Emerging gonadotropin-releasing hormone agonists. Expert Opin Emerg Drugs (2011) 0.78
Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma. Proc Natl Acad Sci U S A (2004) 1.85
GW627368X ((N-{2-[4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist. Br J Pharmacol (2006) 1.17
Functional pharmacology of human prostanoid EP2 and EP4 receptors. Eur J Pharmacol (2004) 0.99
Can intellectualism stifle scientific discovery? Nat Rev Drug Discov (2002) 0.94
Piglet saphenous vein contains multiple relaxatory prostanoid receptors: evidence for EP4, EP2, DP and IP receptor subtypes. Br J Pharmacol (2005) 0.86
Effects of different beta adrenoceptor ligands in mice with permanent occlusion of the left anterior descending coronary artery. Br J Pharmacol (2003) 0.85
Reviewer comments on Reflections on drug research by Sir James Black. Br J Pharmacol (2010) 0.75